Similarity and diversity of the tumor microenvironment in multiple metastases: critical implications for overall and progression-free survival of high-grade serous ovarian cancer

被引:26
|
作者
Heindl, Andreas [1 ,2 ,3 ]
Lan, Chunyan [4 ,5 ]
Rodrigues, Daniel Nava [6 ]
Koelble, Konrad [3 ,7 ]
Yuan, Yinyin [1 ,2 ,3 ]
机构
[1] Inst Canc Res, Ctr Evolut & Canc, London, England
[2] Royal Marsden Hosp, Ctr Mol Pathol, London, England
[3] Inst Canc Res, Div Mol Pathol, London, England
[4] Sun Yat Sen Univ, Dept Gynecol Oncol, Ctr Canc, Guangzhou, Guangdong, Peoples R China
[5] Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China
[6] Inst Canc Res, Div Canc Therapeut, London, England
[7] Royal Marsden Hosp, Dept Histopathol, London, England
基金
英国惠康基金;
关键词
high-grade serous ovarian cancer; locally advanced disease; tumor microenvironment; automated image analysis; ecological diversity; INTRAEPITHELIAL CARCINOMA; OPPORTUNITIES; PERSPECTIVES; BEVACIZUMAB; THERAPIES; INSIGHTS; ECOLOGY; SURGERY; WOMEN;
D O I
10.18632/oncotarget.12106
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The tumor microenvironment is pivotal in influencing cancer progression and metastasis. Different cells co-exist with high spatial diversity within a patient, yet their combinatorial effects are poorly understood. We investigate the similarity of the tumor microenvironment of 192 local metastatic lesions in 61 ovarian cancer patients. An ecologically inspired measure of microenvironmental diversity derived from multiple metastasis sites is correlated with clinicopathological characteristics and prognostic outcome. We demonstrate a high accuracy of our automated analysis across multiple sites. A low level of similarity in microenvironmental composition is observed between ovary tumor and corresponding local metastases (stromal ratio r = 0.30, lymphocyte ratio r = 0.37). We identify a new measure of microenvironmental diversity derived from Shannon entropy that is highly predictive of poor overall (p = 0.002, HR = 3.18, 95% CI = 1.51-6.68) and progression- free survival (p = 0.0036, HR = 2.83, 95% CI = 1.41-5.7), independent of and stronger than clinical variables, subtype stratifications based on single cell types alone and number of sites. Although stromal influence in ovary tumors is known to have significant clinical implications, our findings reveal an even stronger impact orchestrated by diverse cell types. Quantitative histology-based measures can further enable objective selection of patients who are in urgent need of new therapeutic strategies such as combinatorial treatments targeting heterogeneous tumor microenvironment.
引用
收藏
页码:71123 / 71135
页数:13
相关论文
共 50 条
  • [1] Prognostic features of the tumor microenvironment in high-grade serous ovarian cancer and dietary immunomodulation
    Mckenzie, Nathalie D.
    Ahmad, Sarfraz
    Awada, Ahmad
    Kuhn, Theresa M.
    Recio, Fernando O.
    Holloway, Robert W.
    LIFE SCIENCES, 2023, 333
  • [2] The effect of the peritoneal tumor microenvironment on invasion of peritoneal metastases of high-grade serous ovarian cancer and the impact of NEOADJUVANT chemotherapy
    van Baal, J. O. A. M.
    Lok, C. A. R.
    Jordanova, E. S.
    Horlings, H.
    van Driel, W. J.
    Amant, F. C.
    Van de Vijver, K. K.
    VIRCHOWS ARCHIV, 2020, 477 (04) : 535 - 544
  • [3] The effect of the peritoneal tumor microenvironment on invasion of peritoneal metastases of high-grade serous ovarian cancer and the impact of NEOADJUVANT chemotherapy
    J. O. A. M. van Baal
    C. A. R. Lok
    E. S. Jordanova
    H. Horlings
    W. J. van Driel
    F. C. Amant
    K. K. Van de Vijver
    Virchows Archiv, 2020, 477 : 535 - 544
  • [4] Dynamics of the Tumor Immune Microenvironment during Neoadjuvant Chemotherapy of High-Grade Serous Ovarian Cancer
    Lee, Yong Jae
    Woo, Ha Young
    Kim, Yoo-Na
    Park, Junsik
    Nam, Eun Ji
    Kim, Sang Wun
    Kim, Sunghoon
    Kim, Young Tae
    Park, Eunhyang
    Joung, Je-Gun
    Lee, Jung-Yun
    CANCERS, 2022, 14 (09)
  • [5] Habitat radiomics analysis of pet/ct imaging in high-grade serous ovarian cancer: Application to Ki-67 status and progression-free survival
    Wang, Xinghao
    Xu, Chen
    Grzegorzek, Marcin
    Sun, Hongzan
    FRONTIERS IN PHYSIOLOGY, 2022, 13
  • [6] Disparities in treatment modalities and survival among older patients with high-grade serous ovarian cancer
    Cai, Yan
    Shu, Tong
    Zheng, Hong
    BMC WOMENS HEALTH, 2024, 24 (01)
  • [7] In vivo tumor growth of high-grade serous ovarian cancer cell lines
    Mitra, Anirban K.
    Davis, David A.
    Tomar, Sunil
    Roy, Lynn
    Gurler, Hilal
    Xie, Jia
    Lantvit, Daniel D.
    Cardenas, Horacio
    Fang, Fang
    Liu, Yueying
    Loughran, Elizabeth
    Yang, Jing
    Stack, M. Sharon
    Emerson, Robert E.
    Dahl, Karen D. Cowden
    Barbolina, Maria V.
    Nephew, Kenneth P.
    Matei, Daniela
    Burdette, Joanna E.
    GYNECOLOGIC ONCOLOGY, 2015, 138 (02) : 372 - 377
  • [8] Progression-Free Survival Versus Overall Survival in Ovarian Cancer: Where Are We Now?
    Banerjee, Susana
    Kaye, Stan
    CURRENT ONCOLOGY REPORTS, 2012, 14 (06) : 483 - 485
  • [9] Characterization of candidate factors associated with the metastasis and progression of high-grade serous ovarian cancer
    Liu, Huiping
    Zhou, Ling
    Cheng, Hongyan
    Wang, Shang
    Luan, Wenqing
    Cai, E.
    Ye, Xue
    Zhu, Honglan
    Cui, Heng
    Li, Yi
    Chang, Xiaohong
    CHINESE MEDICAL JOURNAL, 2023, 136 (24) : 2974 - 2982
  • [10] Progression-Free Survival Versus Overall Survival in Ovarian Cancer: Where Are We Now?
    Susana Banerjee
    Stan Kaye
    Current Oncology Reports, 2012, 14 : 483 - 485